Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,388 | 15,220 | 41,564 | -107,500 | -73,947 |
| Depreciation Amortization | 92 | 61 | 31 | 219 | 164 |
| Accounts payable and accrued liabilities | -378 | -628 | 166 | 535 | 1,216 |
| Other Working Capital | 437 | 715 | 2,860 | -3,097 | 2,556 |
| Other Operating Activity | -15,091 | -33,694 | -53,459 | 72,322 | 46,295 |
| Operating Cash Flow | $-22,328 | $-18,326 | $-8,838 | $-37,521 | $-23,716 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | N/A | -136 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -137 |
| Investing Cash Flow | $-8 | $-8 | $N/A | $-136 | $-137 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,184 | 7,954 | 3,180 | 35,356 | 31,296 |
| Financing Cash Flow | $16,184 | $7,954 | $3,180 | $35,356 | $31,296 |
| Beginning Cash Position | 48,141 | 48,141 | 48,141 | 50,442 | 50,442 |
| End Cash Position | 41,989 | 37,761 | 42,483 | 48,141 | 57,885 |
| Net Cash Flow | $-6,152 | $-10,380 | $-5,658 | $-2,301 | $7,443 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,328 | -18,326 | -8,838 | -37,521 | -23,716 |
| Capital Expenditure | -8 | -8 | N/A | -136 | N/A |
| Free Cash Flow | -22,336 | -18,334 | -8,838 | -37,657 | -23,716 |